Applied Genetic Technologies Corp. buy melinda
Start price
22.09.17
/
50%
€3.25
Target price
02.10.17
€4.51
Performance (%)
14.58%
End price
02.10.17
€3.72
Summary
This prediction ended on 02.10.17 with a price of €3.72. The BUY prediction by melinda finished with a performance of 14.58%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Applied Genetic Technologies Corp. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by melinda for this prediction
In the thread Applied Genetic Te. diskutieren
Biotechnologie und medizinische SecteurRecherche
Applied Genetic Technologies Corp. ist ein Biotechnologie - Unternehmen in der klinischen Phase, das in der Entwicklung der Gentherapie Produkte entwickelt , zu transformieren , das Leben von Patienten mit schweren Erkrankungen in der Ophthalmologie eingreift. Die Produkte sind so konzipiert , Retinoschisis mit X verknüpft behandeln
Stopped prediction by melinda for Applied Genetic Technologies Corp.
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€4.00
08.04.19
08.04.19
€5.86
04.11.21
04.11.21
-14.11%
01.07.21
01.07.21
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€2.89
12.01.19
12.01.19
€4.06
22.01.19
22.01.19
-12.81%
22.01.19
22.01.19
Applied Genetic Technologies Corp.
Start price
Target price
Perf. (%)
€3.60
22.09.17
22.09.17
€5.00
02.10.17
02.10.17
14.58%
02.10.17
02.10.17